Cargando…
The influence of the combined treatment with Vadimezan (ASA404) and taxol on the growth of U251 glioblastoma xenografts
BACKGROUND: One of the most important biological characteristics of Glioblastoma multiforme (GBM) is high vascular density. Vadimezan (ASA404, DMXAA) belongs to the class of small molecule vascular disrupting agents (VDA) that cause disruption of established tumor vessels and subsequent tumor hemorr...
Autores principales: | Milanović, Dušan, Braun, Friederike, Weber, Wolfgang, Grosu, Anca Ligia, Behe, Martin, Niedermann, Gabriele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476988/ https://www.ncbi.nlm.nih.gov/pubmed/22695475 http://dx.doi.org/10.1186/1471-2407-12-242 |
Ejemplares similares
-
Increased radiosensitivity and radiothermosensitivity of human pancreatic MIA PaCa-2 and U251 glioblastoma cell lines treated with the novel Hsp90 inhibitor NVP-HSP990
por: Milanović, Dušan, et al.
Publicado: (2013) -
MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol
por: Ren, Yu, et al.
Publicado: (2010) -
ASA404, a vascular disrupting agent, as an experimental treatment approach for brain tumors
por: Bähr, Oliver, et al.
Publicado: (2017) -
Effect of Corilagin on the Proliferation and NF-κB in U251 Glioblastoma Cells and U251 Glioblastoma Stem-Like Cells
por: Yang, Wen-Tao, et al.
Publicado: (2016) -
Inhibition of 13-cis retinoic acid-induced gene expression of reactive-resistance genes by thalidomide in glioblastoma tumours in vivo
por: Milanovic, Dusan, et al.
Publicado: (2015)